Cargando…

Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study

Rituximab causes hepatitis B virus (HBV) reactivation in HBV surface antigen (HBsAg)-seronegative patients with CD20-positive B-cell non-Hodgkin lymphoma (CD20(+) NHL), especially for those seropositive to the antibody of core antigen (anti-HBc). Clinical hepatitis usually develops after reverse ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsiao, Liang-Tsai, Chiou, Tzeon-Jye, Gau, Jyh-Pyng, Yang, Ching-Fen, Yu, Yuan-Bin, Liu, Chun-Yu, Liu, Jin-Hwang, Chen, Po-Min, Tzeng, Cheng-Hwai, Chan, Yu-Jiun, Yang, Muh-Hwa, Huang, Yi-Hsiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616669/ https://www.ncbi.nlm.nih.gov/pubmed/26266374 http://dx.doi.org/10.1097/MD.0000000000001321

Ejemplares similares

Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients
por: Hsiao, Liang-Tsai, et al.
Publicado: (2016)

A “Bone Marrow Score” for Predicting Hematological Disease in Immunocompetent Patients With Fevers of Unknown Origin
por: Wang, Hao-Yuan, et al.
Publicado: (2014)

Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
por: Hsu, Pei, et al.
Publicado: (2015)

Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma
por: Huang, Chun-Teng, et al.
Publicado: (2017)

The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification
por: Ko, Po-Shen, et al.
Publicado: (2017)

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022)

Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
por: Liu, Yao-Chung, et al.
Publicado: (2016)

Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes
por: Teng, Chung-Jen, et al.
Publicado: (2011)

Nasopharyngeal Lymphoma: A 22-Year Review of 35 Cases
por: Hsueh, Chien-Yu, et al.
Publicado: (2019)

Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases
por: Laurent, Camille, et al.
Publicado: (2015)

Red and Processed Meat Consumption Increases Risk for Non-Hodgkin Lymphoma: A PRISMA-Compliant Meta-Analysis of Observational Studies
por: Yang, Li, et al.
Publicado: (2015)

Epidermolysis bullosa acquisita as an adverse effect from rituximab therapy: A case report
por: Wu, Xueqiong, et al.
Publicado: (2020)

Correction: Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2018)

Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2017)

Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin’s lymphoma
por: Feng, Xia, et al.
Publicado: (2023)

Primary bone marrow lymphoma: A hematological emergency in adults with fever of unknown origin
por: Wang, Hao‐Yuan, et al.
Publicado: (2018)

Long‐term outcomes of frontline intensification in primary CNS lymphoma: A real‐world single‐center experience
por: Wang, Hao‐Yuan, et al.
Publicado: (2023)

Efficacy and safety evaluation of fludarabine-based chemotherapy regimen for patients with non-Hodgkin lymphoma: A meta-analysis
por: Zhang, Xiaoping, et al.
Publicado: (2017)

Neurolymphomatosis in non-Hodgkin lymphoma with cranial multineuritis: A case report
por: Haydaroglu Sahin, Handan, et al.
Publicado: (2018)

Risk and outcome of second primary malignancy in patients with classical Hodgkin lymphoma
por: Wang, Fan
Publicado: (2022)

Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era
por: Ho, Ching-Liang, et al.
Publicado: (2015)

A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis
por: Charakopoulos, Emmanouil, et al.
Publicado: (2020)

Synchronous Hodgkin lymphoma and gastric adenocarcinoma: A rare case report and literature review
por: Wu, Hongying, et al.
Publicado: (2018)

Model-based meta-analysis of progression-free survival in non-Hodgkin lymphoma patients
por: Li, Mengyao, et al.
Publicado: (2017)

IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020)

Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy
por: Li, Tongjuan, et al.
Publicado: (2020)

Primary B-cell non-Hodgkin lymphoma of the parotid gland: An analysis based on the SEER database
por: Chen, Xiang-Lei, et al.
Publicado: (2023)

Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis
por: Li, Xiao-Mei, et al.
Publicado: (2017)

Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study
por: Zhou, Ji-cheng, et al.
Publicado: (2020)

Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy
por: Tseng, Yu-Hsin, et al.
Publicado: (2016)

Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A and successfully treated with rituximab and rFVIIa: A case report
por: Ma, Hongbing, et al.
Publicado: (2021)

Non-Hodgkin lymphoma of multiple extranodal involvement seen on MRI, FDG PET–CT scans: A case report
por: Wang, Shan, et al.
Publicado: (2017)

Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report
por: Ishiguro, Kazuya, et al.
Publicado: (2020)

Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report
por: Imoto, Naoto, et al.
Publicado: (2021)

Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia
por: Yu, Sijian, et al.
Publicado: (2016)

Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report
por: Hu, Shaoxuan, et al.
Publicado: (2020)

Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating non-Hodgkin lymphoma: A systematic review and meta-analysis of clinical trials
por: Guan, Jiaheng, et al.
Publicado: (2022)

Diagnostic Pitfalls of Discriminating Lymphoma-Associated Effusions
por: Chen, Hung-Jen, et al.
Publicado: (2015)

Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma
por: Lin, Chia-Hsin, et al.
Publicado: (2019)

Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children
por: Chang, Tsung-Yen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1o7gsi3q4aofkhs9pnmt0k43m4